Anne Vanlent
CIK: 0001229243
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRVI
Trevi Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About VANLENT ANNE
VANLENT ANNE (SEC CIK 0001229243) files insider reports with the SEC as Director of Trevi Therapeutics, Inc. (TRVI).
Signal8 holds 2 ownership filings by VANLENT ANNE, all Form 4s, filed between Jun 13, 2025 and Jun 4, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on VANLENT ANNE's filings is in NEW HAVEN, CT.
Recent filings by VANLENT ANNE
Other insiders filing for Trevi Therapeutics, Inc. (TRVI)
- Heffernan Michael Thomas, Director
- Mathers Edward T, Director
- Colangelo Dominick, Director
- Meeker David P, Director
- Cassella James V, Chief Development Officer
- Galletta Christopher